ALT FY 2020 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$331M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+41.1% YoY

Gross Profit

-$25M-309.4% margin

Operating Income

-$55M-669.5% margin

Net Income

-$49M-599.2% margin

EPS (Diluted)

$-1.91

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$35M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$245M

Total Liabilities

$19M

Stockholders' Equity

$226M

Cash & Equivalents

$116M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$6M	+41.1%
Gross Profit	-$25M	$6M	-536.5%
Operating Income	-$55M	-$21M	-155.3%
Net Income	-$49M	-$21M	-139.0%